{"gene":"USP12","run_date":"2026-04-28T21:43:01","timeline":{"discoveries":[{"year":2010,"finding":"USP12 and USP46 deubiquitinate histone H2A and H2B (preferring nucleosomal substrates) in vitro and in vivo; WDR48 (a WD40 repeat protein) interacts with USP12 and USP46 and is required for this histone deubiquitination activity.","method":"In vitro deubiquitination assay with nucleosomal substrates, co-immunoprecipitation, Xenopus knockdown/overexpression with ChIP","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with nucleosomal substrates plus in vivo ChIP validation, replicated in multiple systems","pmids":["21183687"],"is_preprint":false},{"year":2010,"finding":"WDR20, a WD40-repeat protein, forms a ternary complex with USP12 and UAF1 (WDR48), and WDR20 stimulates the enzymatic activity of the USP12·UAF1 complex but not of USP1·UAF1, distinguishing the USP12/USP46 complexes from the USP1 complex.","method":"Tandem affinity purification, co-immunoprecipitation, in vitro deubiquitinase activity assay, siRNA depletion","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — purified ternary complex plus in vitro enzymatic assay with multiple controls","pmids":["20147737"],"is_preprint":false},{"year":2013,"finding":"USP12, in complex with UAF1 and WDR20, deubiquitinates the androgen receptor (AR), enhancing AR protein stability and transcriptional activity in prostate cancer cells.","method":"siRNA screen, co-immunoprecipitation, ubiquitination assay, AR stability and transcriptional reporter assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus functional ubiquitination assay with defined phenotypic readout","pmids":["24056413"],"is_preprint":false},{"year":2013,"finding":"The WDR48·USP12 complex deubiquitinates PHLPP1, stabilizing it and thereby suppressing Akt activation and promoting apoptosis; identified via tandem affinity purification.","method":"Tandem affinity purification, co-immunoprecipitation, ubiquitination/deubiquitination assay, Akt phosphorylation assay, proliferation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — TAP identification followed by biochemical deubiquitination assay with functional downstream readout","pmids":["24145035"],"is_preprint":false},{"year":2012,"finding":"USP12 (with activator UAF1) deubiquitinates the non-activated form of Notch receptor, promoting its trafficking to lysosomes for degradation; USP12 silencing interrupts Notch lysosomal trafficking, increasing surface Notch and Notch signaling activity.","method":"shRNA library screen, in vitro deubiquitination assay, Notch trafficking assay (flow cytometry, confocal imaging), Drosophila homolog validation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro deubiquitination assay plus mechanistic trafficking assay with conserved Drosophila validation","pmids":["22778262"],"is_preprint":false},{"year":2016,"finding":"Crystal structure of USP12-Ub/UAF1 complex (2.8 Å) revealed two UAF1 binding sites; USP12/UAF1 complex has 1:2 stoichiometry with high-affinity (4 nM) and low-affinity (325 nM) binding steps; the fingers subdomain of USP12 mediates the high-affinity UAF1 interface required for activation.","method":"X-ray crystallography, mutagenesis, binding assays (stoichiometry determination), enzymatic activity assays","journal":"Journal of structural biology","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with mutagenesis and functional validation of activation mechanism","pmids":["27650958"],"is_preprint":false},{"year":2016,"finding":"Upon TCR stimulation, USP12 undergoes phosphorylation and translocates from the nucleus to the cytosol; USP12 deubiquitylates LAT and Trat1 (TCR adaptor proteins), preventing their lysosomal degradation and maintaining the proximal TCR complex for sustained NFκB, NFAT, and MAPK signaling.","method":"Activity-based DUB probes (HA-Ub-VME), USP12-KO Jurkat cells, proximity-based BirA labeling, co-immunoprecipitation, rescue experiments, flow cytometry","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — KO cells with rescue, proximity labeling, and defined substrate deubiquitination with signaling phenotype","pmids":["26811477"],"is_preprint":false},{"year":2014,"finding":"USP12, in complex with UAF1 and WDR20, directly deubiquitinates and stabilizes PHLPP and PHLPPL phosphatases, reducing active pAkt levels and consequently decreasing AR phosphorylation at Ser213, thereby enhancing AR stability and transcriptional activity.","method":"Co-immunoprecipitation, ubiquitination/deubiquitination assay, Akt phosphorylation assay, AR transcriptional reporter","journal":"Oncotarget","confidence":"High","confidence_rationale":"Tier 2 — direct deubiquitination assay combined with epistasis-level signaling analysis","pmids":["25216524"],"is_preprint":false},{"year":2018,"finding":"USP12 deubiquitinates MDM2 and AR, controlling TP53 tumor suppressor levels and AR oncogene levels in prostate cancer; identified via transcriptome analysis and denaturing immunoprecipitations.","method":"Transcriptome analysis, denaturing co-immunoprecipitation, immunohistochemistry","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — denaturing IP for substrate identification but limited in vitro reconstitution","pmids":["29755129"],"is_preprint":false},{"year":2018,"finding":"WDR20 promotes recruitment of USP12 (but not USP46) to the plasma membrane, and the USP12/UAF1/WDR20 complex dynamically shuttles between plasma membrane, cytoplasm, and nucleus via CRM1-dependent nuclear export; this requires a short N-terminal motif (1MEIL4) in USP12 and a NES in WDR20.","method":"Confocal and live microscopy, site-directed mutagenesis, CRM1 inhibitor (leptomycin B) treatment, co-immunoprecipitation","journal":"European journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2–3 — direct localization experiments with mutagenesis, but functional consequence of shuttling not fully defined","pmids":["30466959"],"is_preprint":false},{"year":2020,"finding":"USP12 interacts with the HAT domain of CBP and inhibits CBP acetyltransferase activity independently of its deubiquitinase activity; during IFN signaling, USP12 translocates from cytoplasm to nucleus, where nuclear USP12 accumulation blocks CBP-mediated acetylation of phospho-STAT1, inhibiting TCPTP-dependent dephosphorylation and maintaining nuclear p-STAT1 levels.","method":"Co-immunoprecipitation, CBP acetyltransferase activity assay, subcellular fractionation, catalytic mutant USP12, p-STAT1 dephosphorylation assay","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 2 — enzymatic assay for CBP inhibition plus localization with functional readout, single study","pmids":["31899788"],"is_preprint":false},{"year":2021,"finding":"USP12 interacts with, deubiquitylates, and stabilizes HMGB1, sustaining HMGB1-mediated pro-survival autophagy and contributing to bortezomib resistance in multiple myeloma.","method":"Co-immunoprecipitation, ubiquitination assay, USP12 knockdown, autophagy flux assay","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP plus deubiquitination assay with functional autophagy phenotype, single lab","pmids":["34997217"],"is_preprint":false},{"year":2021,"finding":"USP12 deubiquitinates and stabilizes PPM1B (a phosphatase), and USP12 downregulation causes insufficient PPM1B deubiquitination leading to NF-κB hyperactivation in tumor cells, creating an immunosuppressive microenvironment.","method":"Co-immunoprecipitation, ubiquitination assay, USP12 KO mouse lung tumor model, NF-κB reporter","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo KO model plus biochemical deubiquitination assay, single lab","pmids":["34381028"],"is_preprint":false},{"year":2021,"finding":"USP12 stabilizes BCL10 by deubiquitinating it, thereby activating NF-κB signaling specifically in CD4+ T cells to promote their activation, differentiation, and proliferation.","method":"USP12-KO mouse model, co-immunoprecipitation, ubiquitination assay, NF-κB signaling assay, CD4+ T cell functional assays","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse plus biochemical deubiquitination assay, single lab","pmids":["33941870"],"is_preprint":false},{"year":2021,"finding":"USP12 binds and stabilizes p300 by deubiquitination, upregulating p300-dependent transcription of METTL3, which catalyzes m6A modification on mRNAs and promotes cardiac hypertrophy.","method":"Co-immunoprecipitation, ubiquitination assay, USP12 KO/OE in cardiomyocytes and in vivo, METTL3 rescue experiment","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP plus ubiquitination assay with in vivo model, single lab","pmids":["34339675"],"is_preprint":false},{"year":2021,"finding":"USP12 deubiquitinates and stabilizes midkine (MDK) in breast cancer cells, preventing its polyubiquitination-mediated degradation and promoting tumor angiogenesis.","method":"Co-immunoprecipitation, ubiquitination assay, MDK overexpression rescue, HUVEC tube formation and migration assays, in vivo metastasis model","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2–3 — direct Co-IP plus deubiquitination assay with functional rescue, single lab","pmids":["34759262"],"is_preprint":false},{"year":2022,"finding":"USP12 deubiquitinates and stabilizes p65 (NF-κB subunit) in monocytic MDSCs, upregulating iNOS and PD-L1 expression to suppress CD8+ T cell responses and promote tumor immune evasion.","method":"Co-immunoprecipitation, ubiquitination assay, USP12-KO mouse model, T cell suppression assay","journal":"Immunology","confidence":"Medium","confidence_rationale":"Tier 2–3 — KO model plus biochemical deubiquitination, single lab","pmids":["35898171"],"is_preprint":false},{"year":2022,"finding":"USP12 interacts with Bax and removes K63-linked ubiquitin chains from Bax (at K128 and K190 sites), affecting Bax protein half-life without targeting it for proteasomal degradation.","method":"Yeast two-hybrid, co-immunoprecipitation, site-directed mutagenesis of Bax ubiquitination sites, half-life assay","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2–3 — Y2H plus mutagenesis of ubiquitination sites, but functional consequence of K63-deubiquitination not fully resolved","pmids":["36361894"],"is_preprint":false},{"year":2023,"finding":"USP12 inhibits proteasome-dependent degradation of IFI16 through its deubiquitinase activity, maintaining IFI16 stability and promoting IFI16-STING-IRF3/p65-mediated antiviral signaling against HSV-1.","method":"USP12 KO/KD, co-immunoprecipitation, ubiquitination assay, IFN-β/ISG expression assay, viral replication assay","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 2–3 — KO plus deubiquitination assay with defined antiviral signaling readout, single lab","pmids":["37410794"],"is_preprint":false},{"year":2023,"finding":"USP12 directly interacts with and deubiquitinates RRM2 (ribonucleotide reductase catalytic subunit), stabilizing it in non-small cell lung cancer cells; USP12 knockdown causes DNA replication stress.","method":"Co-immunoprecipitation, ubiquitination assay, USP12 KD, DNA replication stress markers, in vivo tumor growth assay","journal":"Molecular carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2–3 — direct Co-IP and deubiquitination assay with functional DNA replication readout, single lab","pmids":["37341611"],"is_preprint":false},{"year":2024,"finding":"USP12/46-WDR48-WDR20 ternary complex removes ubiquitin from the cytoplasmic tail of internalized β1 integrin (Itgb1) in early endosomes, preventing ESCRT-mediated sorting and lysosomal degradation, thereby stabilizing integrin surface levels.","method":"Genetic screen, proximity-dependent biotin identification (BioID), co-immunoprecipitation, integrin surface level assay, ESCRT pathway analysis","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — BioID plus genetic screen with mechanistic deubiquitination in endosomal trafficking context, preprint","pmids":["bio_10.1101_2024.05.14.594138"],"is_preprint":true},{"year":2024,"finding":"WDR20 and USP12/46 co-deubiquitinate c-Myc simultaneously to maintain its stability; WDR20 silencing disturbs c-Myc protein stability, promoting CDKN1A transcription and HCC cellular senescence.","method":"siRNA screen of WDR-domain proteins, co-immunoprecipitation, ubiquitination assay, ChIP, patient-derived organoids, xenograft and transgenic mouse models","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — biochemical deubiquitination assay with multiple in vivo models, single lab","pmids":["39432777"],"is_preprint":false},{"year":2024,"finding":"USP12 interacts with YAP, inhibits K48-linked polyubiquitination of YAP at K315, and stabilizes YAP in the nucleus to promote Hippo/YAP signaling in gastric cancer.","method":"DUB siRNA library screen, co-immunoprecipitation, ubiquitination site mutagenesis (K315R), immunostaining for nuclear localization, in vitro and in vivo tumor growth assays","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2–3 — DUB library screen plus mutagenesis of ubiquitination site and nuclear localization assay, single lab","pmids":["38605077"],"is_preprint":false},{"year":2021,"finding":"DMWD (dystrophia myotonica WD repeat protein), analogous to WDR20, directly binds USP12 at the same interface as WDR20 (suggesting mutually exclusive binding), promotes USP12 enzymatic activity, but differentially modulates USP12 subcellular localization compared to WDR20.","method":"Co-immunoprecipitation of epitope-tagged proteins, enzymatic activity assay, subcellular localization imaging, phylogenetic analysis","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2–3 — direct Co-IP plus enzymatic assay and localization experiment, single lab","pmids":["33844468"],"is_preprint":false},{"year":2024,"finding":"METTL3/YTHDF1-mediated m6A modification stabilizes USP12 mRNA; elevated USP12 then interacts with and deubiquitinates FOXO3, preventing its ubiquitin-mediated degradation and leading to PUMA upregulation and intrinsic apoptosis in sepsis-induced myocardial dysfunction.","method":"Proteomic profiling, m6A modification analysis, co-immunoprecipitation, ubiquitination assay, in vitro/in vivo LPS-SIMD model, pathway inhibitor experiments","journal":"Molecular immunology","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP plus ubiquitination assay with in vivo model, single lab","pmids":["39662205"],"is_preprint":false}],"current_model":"USP12 is a deubiquitinating enzyme that forms an obligate ternary complex with UAF1 (WDR48) and WDR20 (or DMWD) for full enzymatic activation; this complex deubiquitinates a broad range of substrates—including histones H2A/H2B, the androgen receptor, MDM2, Notch, PHLPP1/2, LAT, Trat1, BCL10, p65, HMGB1, IFI16, YAP, RRM2, midkine, β1 integrin, c-Myc, FOXO3, p300, PPM1B, and Bax—to regulate their stability and thereby control diverse processes including transcription, PI3K-Akt-NF-κB signaling, TCR and innate immune signaling, Notch and Hippo pathway trafficking, autophagy, cell cycle progression, and integrin recycling; additionally, USP12 can inhibit CBP acetyltransferase activity independently of its catalytic DUB function, and its subcellular localization (plasma membrane, cytoplasm, nucleus) is dynamically regulated by WDR20 via CRM1-dependent nuclear export."},"narrative":{"teleology":[{"year":2010,"claim":"Identification of USP12 as a histone-directed DUB and discovery of its obligate activator UAF1/WDR48 established that USP12 requires a WD40-repeat cofactor for catalytic competence, setting it apart from most USP-family members.","evidence":"In vitro deubiquitination of nucleosomal H2A/H2B, co-IP with WDR48, Xenopus knockdown/overexpression with ChIP","pmids":["21183687"],"confidence":"High","gaps":["Whether UAF1 binding induces conformational change or allosteric activation was unresolved","Relative contributions of H2A vs H2B deubiquitination to transcriptional output not determined"]},{"year":2010,"claim":"Discovery that WDR20 forms a ternary complex with USP12–UAF1 and specifically stimulates USP12 (but not USP1) activity revealed a second cofactor layer that distinguishes USP12/USP46 from other UAF1-dependent DUBs.","evidence":"Tandem affinity purification, in vitro DUB activity assay with recombinant ternary complex","pmids":["20147737"],"confidence":"High","gaps":["Mechanism by which WDR20 stimulates activity unknown at this point","Physiological substrates of the full ternary complex not yet identified"]},{"year":2012,"claim":"Demonstrating that USP12 deubiquitinates non-activated Notch to promote its lysosomal trafficking revealed the first non-histone substrate and placed USP12 in endosomal sorting, where deubiquitination paradoxically promotes degradation rather than stabilization.","evidence":"shRNA screen, in vitro DUB assay on Notch, trafficking assay by flow cytometry and confocal imaging, Drosophila homolog validation","pmids":["22778262"],"confidence":"High","gaps":["Whether USP12 acts on Notch at the plasma membrane vs endosome not resolved","Identity of the E3 ligase counteracting USP12 on Notch unknown"]},{"year":2013,"claim":"Identification of the androgen receptor and PHLPP phosphatases as USP12 substrates connected the enzyme to two converging oncogenic pathways—AR transcription and PI3K–Akt signaling—in prostate cancer.","evidence":"Co-IP, ubiquitination/deubiquitination assays, Akt phosphorylation and AR reporter assays in prostate cancer cells","pmids":["24056413","24145035"],"confidence":"High","gaps":["Whether AR and PHLPP are deubiquitinated by the same pool of USP12 complex unknown","No structural basis for substrate recognition"]},{"year":2016,"claim":"The crystal structure of USP12–Ub bound to UAF1 resolved the activation mechanism, revealing a 1:2 stoichiometry with high- and low-affinity UAF1 binding sites mediated by the USP12 fingers subdomain.","evidence":"X-ray crystallography at 2.8 Å, mutagenesis, binding stoichiometry assays","pmids":["27650958"],"confidence":"High","gaps":["Structure of the full ternary complex including WDR20 not determined","Structural basis for substrate selectivity remains unknown"]},{"year":2016,"claim":"Showing that USP12 is phosphorylated and translocates from nucleus to cytosol upon TCR stimulation to deubiquitinate LAT and Trat1 established USP12 as a signal-dependent effector in adaptive immunity that maintains proximal TCR signaling complexes.","evidence":"Activity-based DUB probes, USP12-KO Jurkat cells with rescue, BioID proximity labeling, co-IP, flow cytometry","pmids":["26811477"],"confidence":"High","gaps":["Kinase responsible for USP12 phosphorylation not identified","Whether USP12 acts similarly in primary human T cells not confirmed"]},{"year":2018,"claim":"Characterization of USP12's dynamic subcellular shuttling—WDR20 recruits USP12 to the plasma membrane while CRM1-dependent export controls nuclear exit—explained how a single DUB accesses substrates in distinct compartments.","evidence":"Confocal and live-cell microscopy, mutagenesis of N-terminal MEIL motif, leptomycin B treatment","pmids":["30466959"],"confidence":"Medium","gaps":["Functional consequence of membrane localization for specific substrates not defined","Whether phosphorylation regulates this shuttling is untested"]},{"year":2020,"claim":"Discovery that USP12 inhibits CBP acetyltransferase activity independently of its DUB catalytic function revealed a non-enzymatic role in sustaining nuclear phospho-STAT1 during IFN signaling, broadening USP12's functional repertoire beyond deubiquitination.","evidence":"CBP HAT activity assay with catalytic-dead USP12 mutant, subcellular fractionation, p-STAT1 dephosphorylation assay","pmids":["31899788"],"confidence":"Medium","gaps":["Structural basis for CBP HAT domain inhibition not resolved","Whether this non-catalytic function extends to other acetyltransferases untested","Single-study finding"]},{"year":2021,"claim":"A burst of substrate identifications—HMGB1, PPM1B, BCL10, p300, midkine, Bax, and DMWD as an alternative WDR20-like cofactor—collectively demonstrated that USP12 is a broadly acting stabilizer of signaling regulators across NF-κB, autophagy, apoptosis, and epigenetic pathways.","evidence":"Multiple independent Co-IP and ubiquitination assays, KO mouse models (PPM1B, BCL10), autophagy flux (HMGB1), cardiomyocyte models (p300), Bax mutagenesis","pmids":["34997217","34381028","33941870","34339675","34759262","36361894","33844468"],"confidence":"Medium","gaps":["Most substrates validated by single labs; independent replication needed","Hierarchy or competition among substrates for USP12 binding is unexplored","Whether DMWD and WDR20 direct USP12 to distinct substrate pools is unresolved"]},{"year":2023,"claim":"Identification of IFI16 and RRM2 as USP12 substrates extended its roles to innate antiviral immunity (IFI16–STING–IRF3 axis) and DNA replication (dNTP supply via RRM2 stability), linking USP12 to genome maintenance.","evidence":"USP12 KO/KD with Co-IP and ubiquitination assays, IFN-β/ISG induction and viral replication assays (IFI16), DNA replication stress markers and in vivo tumor growth (RRM2)","pmids":["37410794","37341611"],"confidence":"Medium","gaps":["Whether USP12 regulates RRM2 during normal S-phase or only under oncogenic stress unclear","Redundancy with USP46 for these substrates not assessed"]},{"year":2024,"claim":"Studies on YAP, c-Myc, β1 integrin, and FOXO3 further expanded the USP12 substrate repertoire to Hippo signaling, oncogene stabilization, endosomal integrin recycling, and sepsis-induced apoptosis, underscoring USP12 as a context-dependent stabilizer of diverse signaling nodes.","evidence":"DUB siRNA screens, BioID and genetic screens (integrin), Co-IP with ubiquitination site mutagenesis (YAP K315), patient-derived organoids and transgenic mice (c-Myc), LPS-SIMD models (FOXO3)","pmids":["38605077","39432777","39662205"],"confidence":"Medium","gaps":["Integrin deubiquitination data from preprint awaiting peer review","How USP12 distinguishes >20 substrates through a single catalytic domain lacks structural explanation","Relative physiological importance of individual substrates in vivo not ranked"]},{"year":null,"claim":"Key unresolved questions include: (1) the structural basis for WDR20/DMWD-dependent activation and substrate selectivity in the full ternary complex, (2) whether distinct cofactor combinations (WDR20 vs DMWD) channel USP12 to specific substrate pools in vivo, and (3) how signal-dependent post-translational modifications orchestrate USP12 localization and substrate access across its many reported pathways.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structure of USP12–UAF1–WDR20 ternary complex","Kinase(s) and phosphorylation sites controlling USP12 relocalization unidentified","Systematic comparison of USP12 vs USP46 substrate specificity lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,2,3,4,6,8,11,12,13,14,15,16,17,18,19,22,24]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[10]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[6,9,10,22]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[6,9]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[9]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[4,20]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,4,6,7,12,13,16,22]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[6,13,16,18]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[0]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,8,14]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[17,24]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[11]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[4,20]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[8,15,19,21,22]}],"complexes":["USP12–UAF1(WDR48)–WDR20 ternary complex","USP12–UAF1(WDR48)–DMWD ternary complex"],"partners":["WDR48","WDR20","DMWD","AR","PHLPP1","CREBBP","MDM2","LAT"],"other_free_text":[]},"mechanistic_narrative":"USP12 is a deubiquitinating enzyme that functions as the catalytic subunit of a ternary complex with the WD40-repeat proteins UAF1 (WDR48) and WDR20, which are required for full enzymatic activation and proper subcellular localization [PMID:20147737, PMID:27650958, PMID:30466959]. The USP12–UAF1–WDR20 complex deubiquitinates a remarkably broad substrate repertoire—including histones H2A/H2B, the androgen receptor, PHLPP phosphatases, Notch, MDM2, NF-κB pathway components (BCL10, p65, PPM1B), innate immune sensors (IFI16), and endosomal cargo (β1 integrin)—thereby stabilizing these proteins and controlling transcription, PI3K–Akt signaling, TCR and innate immune signaling, Notch trafficking, and integrin recycling [PMID:21183687, PMID:24056413, PMID:24145035, PMID:22778262, PMID:26811477, PMID:33941870, PMID:37410794]. In addition to its catalytic deubiquitinase function, USP12 inhibits CBP acetyltransferase activity through a non-catalytic mechanism, sustaining nuclear phospho-STAT1 during interferon signaling [PMID:31899788]. USP12 dynamically shuttles between the plasma membrane, cytoplasm, and nucleus via CRM1-dependent export directed by WDR20, with TCR or IFN stimulation triggering redistribution that dictates substrate access [PMID:30466959, PMID:26811477]."},"prefetch_data":{"uniprot":{"accession":"O75317","full_name":"Ubiquitin carboxyl-terminal hydrolase 12","aliases":["Deubiquitinating enzyme 12","Ubiquitin specific peptidase 12","Ubiquitin thioesterase 12","Ubiquitin-hydrolyzing enzyme 1","Ubiquitin-specific-processing protease 12"],"length_aa":370,"mass_kda":42.9,"function":"Deubiquitinating enzyme that plays various roles in the regulation of the immune response and inflammation (PubMed:19075014, PubMed:27373336). During TCR engagement and activation, translocates into the cytoplasm and deubiquitinates its substrates LAT and TRAT1 and prevents their lysosome-dependent degradation to stabilize the TCR signaling complex at the plasma membrane (PubMed:26811477). Plays an essential role in the selective LPS-induced macrophage response through the activation of NF-kappa-B pathway (PubMed:28063927). In addition, promotes that antiviral immune response through targeting DNA sensor IFI16 to inhibit its proteasome-dependent degradation (PubMed:37410794). Participates in the interferon signaling pathway and antiviral response independently of its deubiquitinase activity by maintaining nuclear phosphorylated STAT1 levels via inhibition of its CREBBP-mediated acetylation and subsequent dephosphorylation (PubMed:31899788). Plays an intrinsic role in promoting the differentiation, activation and proliferation of CD4(+) T-cell by activating the NF-kappa-B signaling pathway through deubiquitinating and stabilizing B-cell lymphoma/leukemia 10/BCL10 (By similarity). In myeloid-derived suppressor cells promotes the activation of the NF-kappa-B via deubiquitination and stabilization of RELA (By similarity). Regulates the 'Lys-63'-linked polyubiquitin chains of BAX and thereby modulates the mitochondrial apoptotic process (PubMed:36361894). Negative regulator of NOTCH signaling that specifically deubiquitinates non-activated NOTCH receptors to target them for lysosomal degradation; deubiquitination of NOTCH stimulates its transport form late endosomes to lysosomes (PubMed:22778262). Protects neurons against HTT/huntingtin-induced polyglutamine expansion-dependent neurodegeneration through regulation of autophagic flux (PubMed:30266909). This function is independent of deubiquitinase activity or of other components of the USP12-WDR20-WDR48 deubiquitinating complex (By similarity). In complex with WDR48, acts as a potential tumor suppressor by positively regulating PHLPP1 stability (PubMed:24145035) (Microbial infection) Forms a complex with Epstein-Barr virus protein EBNA3 which is an active deubiquitinase activity that may select specific substrates to promote B-lymphocyte transformation","subcellular_location":"Nucleus; Cytoplasm; Cell membrane","url":"https://www.uniprot.org/uniprotkb/O75317/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/USP12","classification":"Not Classified","n_dependent_lines":7,"n_total_lines":1208,"dependency_fraction":0.005794701986754967},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/USP12","total_profiled":1310},"omim":[{"mim_id":"617741","title":"WD REPEAT-CONTAINING PROTEIN 20; WDR20","url":"https://www.omim.org/entry/617741"},{"mim_id":"612167","title":"WD REPEAT-CONTAINING PROTEIN 48; WDR48","url":"https://www.omim.org/entry/612167"},{"mim_id":"603091","title":"UBIQUITIN-SPECIFIC PROTEASE 12; USP12","url":"https://www.omim.org/entry/603091"},{"mim_id":"190198","title":"NOTCH RECEPTOR 1; NOTCH1","url":"https://www.omim.org/entry/190198"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/USP12"},"hgnc":{"alias_symbol":[],"prev_symbol":["USP12L1"]},"alphafold":{"accession":"O75317","domains":[{"cath_id":"3.90.70.10","chopping":"33-143_171-367","consensus_level":"medium","plddt":93.8771,"start":33,"end":367}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O75317","model_url":"https://alphafold.ebi.ac.uk/files/AF-O75317-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O75317-F1-predicted_aligned_error_v6.png","plddt_mean":88.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=USP12","jax_strain_url":"https://www.jax.org/strain/search?query=USP12"},"sequence":{"accession":"O75317","fasta_url":"https://rest.uniprot.org/uniprotkb/O75317.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O75317/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O75317"}},"corpus_meta":[{"pmid":"21183687","id":"PMC_21183687","title":"Regulation of histone H2A and H2B deubiquitination and Xenopus development by USP12 and USP46.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21183687","citation_count":98,"is_preprint":false},{"pmid":"20147737","id":"PMC_20147737","title":"WDR20 regulates activity of the USP12 x UAF1 deubiquitinating enzyme complex.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20147737","citation_count":80,"is_preprint":false},{"pmid":"24056413","id":"PMC_24056413","title":"Deubiquitinating enzyme Usp12 is a novel co-activator of the androgen receptor.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24056413","citation_count":75,"is_preprint":false},{"pmid":"24145035","id":"PMC_24145035","title":"WD repeat protein WDR48 in complex with deubiquitinase USP12 suppresses Akt-dependent cell survival signaling by stabilizing PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1).","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24145035","citation_count":62,"is_preprint":false},{"pmid":"22778262","id":"PMC_22778262","title":"The ubiquitin-specific protease 12 (USP12) is a negative regulator of notch signaling acting on notch receptor trafficking toward degradation.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22778262","citation_count":60,"is_preprint":false},{"pmid":"25855980","id":"PMC_25855980","title":"The EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growth.","date":"2015","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/25855980","citation_count":49,"is_preprint":false},{"pmid":"25216524","id":"PMC_25216524","title":"Deubiquitinating enzyme Usp12 regulates the interaction between the androgen receptor and the Akt pathway.","date":"2014","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25216524","citation_count":47,"is_preprint":false},{"pmid":"26811477","id":"PMC_26811477","title":"Usp12 stabilizes the T-cell receptor complex at the cell surface during signaling.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26811477","citation_count":44,"is_preprint":false},{"pmid":"34381028","id":"PMC_34381028","title":"USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34381028","citation_count":41,"is_preprint":false},{"pmid":"29755129","id":"PMC_29755129","title":"Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP12.","date":"2018","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/29755129","citation_count":36,"is_preprint":false},{"pmid":"34997217","id":"PMC_34997217","title":"Deubiquitylase USP12 induces pro-survival autophagy and bortezomib resistance in multiple myeloma by stabilizing HMGB1.","date":"2022","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/34997217","citation_count":35,"is_preprint":false},{"pmid":"34339675","id":"PMC_34339675","title":"De-ubiquitination of p300 by USP12 Critically Enhances METTL3 Expression and Ang II-induced cardiac hypertrophy.","date":"2021","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/34339675","citation_count":31,"is_preprint":false},{"pmid":"27650958","id":"PMC_27650958","title":"A conserved two-step binding for the UAF1 regulator to the USP12 deubiquitinating enzyme.","date":"2016","source":"Journal of structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/27650958","citation_count":29,"is_preprint":false},{"pmid":"29861848","id":"PMC_29861848","title":"The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survival.","date":"2018","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29861848","citation_count":24,"is_preprint":false},{"pmid":"31899788","id":"PMC_31899788","title":"USP12 translocation maintains interferon antiviral efficacy by inhibiting CBP acetyltransferase activity.","date":"2020","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/31899788","citation_count":22,"is_preprint":false},{"pmid":"34759262","id":"PMC_34759262","title":"USP12 promotes breast cancer angiogenesis by maintaining midkine stability.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34759262","citation_count":20,"is_preprint":false},{"pmid":"33941870","id":"PMC_33941870","title":"USP12 promotes CD4+ T cell responses through deubiquitinating and stabilizing BCL10.","date":"2021","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/33941870","citation_count":19,"is_preprint":false},{"pmid":"26680102","id":"PMC_26680102","title":"USP12 regulates cell cycle progression by involving c-Myc, cyclin D2 and BMI-1.","date":"2015","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/26680102","citation_count":17,"is_preprint":false},{"pmid":"37410794","id":"PMC_37410794","title":"USP12 promotes antiviral responses by deubiquitinating and stabilizing IFI16.","date":"2023","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/37410794","citation_count":16,"is_preprint":false},{"pmid":"35898171","id":"PMC_35898171","title":"USP12 positively regulates M-MDSC function to inhibit antitumour immunity through deubiquitinating and stabilizing p65.","date":"2022","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35898171","citation_count":15,"is_preprint":false},{"pmid":"39432777","id":"PMC_39432777","title":"WDR20 prevents hepatocellular carcinoma senescence by orchestrating the simultaneous USP12/46-mediated deubiquitination of c-Myc.","date":"2024","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/39432777","citation_count":13,"is_preprint":false},{"pmid":"37752518","id":"PMC_37752518","title":"Spotlights on ubiquitin-specific protease 12 (USP12) in diseases: from multifaceted roles to pathophysiological mechanisms.","date":"2023","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37752518","citation_count":11,"is_preprint":false},{"pmid":"28063927","id":"PMC_28063927","title":"Deubiquitinase USP12 promotes LPS induced macrophage responses through inhibition of IκBα.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28063927","citation_count":11,"is_preprint":false},{"pmid":"37341611","id":"PMC_37341611","title":"USP12 promotes nonsmall cell lung cancer progression through deubiquitinating and stabilizing RRM2.","date":"2023","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/37341611","citation_count":10,"is_preprint":false},{"pmid":"36361894","id":"PMC_36361894","title":"Deubiquitinating Enzyme USP12 Regulates the Pro-Apoptosis Protein Bax.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36361894","citation_count":10,"is_preprint":false},{"pmid":"38605077","id":"PMC_38605077","title":"USP12 facilitates gastric cancer progression via stabilizing YAP.","date":"2024","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/38605077","citation_count":10,"is_preprint":false},{"pmid":"30466959","id":"PMC_30466959","title":"WDR20 regulates shuttling of the USP12 deubiquitinase complex between the plasma membrane, cytoplasm and nucleus.","date":"2018","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30466959","citation_count":9,"is_preprint":false},{"pmid":"38113977","id":"PMC_38113977","title":"USP12 regulates ER stress-associated osteogenesis in human periodontal ligament cells under tension stress.","date":"2023","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/38113977","citation_count":9,"is_preprint":false},{"pmid":"33174033","id":"PMC_33174033","title":"Downregulation of USP12 inhibits tumor growth via the p38/MAPK pathway in hepatocellular carcinoma.","date":"2020","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/33174033","citation_count":8,"is_preprint":false},{"pmid":"35032679","id":"PMC_35032679","title":"Grouper USP12 exerts antiviral activity against nodavirus infection.","date":"2022","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35032679","citation_count":6,"is_preprint":false},{"pmid":"39662205","id":"PMC_39662205","title":"METTL3/YTHDF1-mediated m6A modification stabilizes USP12 to deubiquitinate FOXO3 and promote apoptosis in sepsis-induced myocardial dysfunction.","date":"2024","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/39662205","citation_count":5,"is_preprint":false},{"pmid":"33844468","id":"PMC_33844468","title":"The dystrophia myotonica WD repeat-containing protein DMWD and WDR20 differentially regulate USP12 deubiquitinase.","date":"2021","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/33844468","citation_count":3,"is_preprint":false},{"pmid":"39700963","id":"PMC_39700963","title":"Membrane palmitoylated protein MPP1 inhibits immune escape by regulating the USP12/ CCL5 axis in urothelial carcinoma.","date":"2024","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39700963","citation_count":3,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.05.24.25328240","title":"Genetic and Epigenetic Foundations of Childhood Internalizing and Externalizing Problems and their Co-occurrence","date":"2025-05-25","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.24.25328240","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.05.14.594138","title":"The USP12/46 deubiquitinases protect integrins from ESCRT-mediated lysosomal degradation","date":"2024-05-17","source":"bioRxiv","url":"https://doi.org/10.1101/2024.05.14.594138","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":18064,"output_tokens":5630,"usd":0.069321},"stage2":{"model":"claude-opus-4-6","input_tokens":9287,"output_tokens":3595,"usd":0.204465},"total_usd":0.273786,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2010,\n      \"finding\": \"USP12 and USP46 deubiquitinate histone H2A and H2B (preferring nucleosomal substrates) in vitro and in vivo; WDR48 (a WD40 repeat protein) interacts with USP12 and USP46 and is required for this histone deubiquitination activity.\",\n      \"method\": \"In vitro deubiquitination assay with nucleosomal substrates, co-immunoprecipitation, Xenopus knockdown/overexpression with ChIP\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with nucleosomal substrates plus in vivo ChIP validation, replicated in multiple systems\",\n      \"pmids\": [\"21183687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"WDR20, a WD40-repeat protein, forms a ternary complex with USP12 and UAF1 (WDR48), and WDR20 stimulates the enzymatic activity of the USP12·UAF1 complex but not of USP1·UAF1, distinguishing the USP12/USP46 complexes from the USP1 complex.\",\n      \"method\": \"Tandem affinity purification, co-immunoprecipitation, in vitro deubiquitinase activity assay, siRNA depletion\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — purified ternary complex plus in vitro enzymatic assay with multiple controls\",\n      \"pmids\": [\"20147737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"USP12, in complex with UAF1 and WDR20, deubiquitinates the androgen receptor (AR), enhancing AR protein stability and transcriptional activity in prostate cancer cells.\",\n      \"method\": \"siRNA screen, co-immunoprecipitation, ubiquitination assay, AR stability and transcriptional reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus functional ubiquitination assay with defined phenotypic readout\",\n      \"pmids\": [\"24056413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The WDR48·USP12 complex deubiquitinates PHLPP1, stabilizing it and thereby suppressing Akt activation and promoting apoptosis; identified via tandem affinity purification.\",\n      \"method\": \"Tandem affinity purification, co-immunoprecipitation, ubiquitination/deubiquitination assay, Akt phosphorylation assay, proliferation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — TAP identification followed by biochemical deubiquitination assay with functional downstream readout\",\n      \"pmids\": [\"24145035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"USP12 (with activator UAF1) deubiquitinates the non-activated form of Notch receptor, promoting its trafficking to lysosomes for degradation; USP12 silencing interrupts Notch lysosomal trafficking, increasing surface Notch and Notch signaling activity.\",\n      \"method\": \"shRNA library screen, in vitro deubiquitination assay, Notch trafficking assay (flow cytometry, confocal imaging), Drosophila homolog validation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro deubiquitination assay plus mechanistic trafficking assay with conserved Drosophila validation\",\n      \"pmids\": [\"22778262\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Crystal structure of USP12-Ub/UAF1 complex (2.8 Å) revealed two UAF1 binding sites; USP12/UAF1 complex has 1:2 stoichiometry with high-affinity (4 nM) and low-affinity (325 nM) binding steps; the fingers subdomain of USP12 mediates the high-affinity UAF1 interface required for activation.\",\n      \"method\": \"X-ray crystallography, mutagenesis, binding assays (stoichiometry determination), enzymatic activity assays\",\n      \"journal\": \"Journal of structural biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with mutagenesis and functional validation of activation mechanism\",\n      \"pmids\": [\"27650958\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Upon TCR stimulation, USP12 undergoes phosphorylation and translocates from the nucleus to the cytosol; USP12 deubiquitylates LAT and Trat1 (TCR adaptor proteins), preventing their lysosomal degradation and maintaining the proximal TCR complex for sustained NFκB, NFAT, and MAPK signaling.\",\n      \"method\": \"Activity-based DUB probes (HA-Ub-VME), USP12-KO Jurkat cells, proximity-based BirA labeling, co-immunoprecipitation, rescue experiments, flow cytometry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO cells with rescue, proximity labeling, and defined substrate deubiquitination with signaling phenotype\",\n      \"pmids\": [\"26811477\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"USP12, in complex with UAF1 and WDR20, directly deubiquitinates and stabilizes PHLPP and PHLPPL phosphatases, reducing active pAkt levels and consequently decreasing AR phosphorylation at Ser213, thereby enhancing AR stability and transcriptional activity.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination/deubiquitination assay, Akt phosphorylation assay, AR transcriptional reporter\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct deubiquitination assay combined with epistasis-level signaling analysis\",\n      \"pmids\": [\"25216524\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"USP12 deubiquitinates MDM2 and AR, controlling TP53 tumor suppressor levels and AR oncogene levels in prostate cancer; identified via transcriptome analysis and denaturing immunoprecipitations.\",\n      \"method\": \"Transcriptome analysis, denaturing co-immunoprecipitation, immunohistochemistry\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — denaturing IP for substrate identification but limited in vitro reconstitution\",\n      \"pmids\": [\"29755129\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"WDR20 promotes recruitment of USP12 (but not USP46) to the plasma membrane, and the USP12/UAF1/WDR20 complex dynamically shuttles between plasma membrane, cytoplasm, and nucleus via CRM1-dependent nuclear export; this requires a short N-terminal motif (1MEIL4) in USP12 and a NES in WDR20.\",\n      \"method\": \"Confocal and live microscopy, site-directed mutagenesis, CRM1 inhibitor (leptomycin B) treatment, co-immunoprecipitation\",\n      \"journal\": \"European journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct localization experiments with mutagenesis, but functional consequence of shuttling not fully defined\",\n      \"pmids\": [\"30466959\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"USP12 interacts with the HAT domain of CBP and inhibits CBP acetyltransferase activity independently of its deubiquitinase activity; during IFN signaling, USP12 translocates from cytoplasm to nucleus, where nuclear USP12 accumulation blocks CBP-mediated acetylation of phospho-STAT1, inhibiting TCPTP-dependent dephosphorylation and maintaining nuclear p-STAT1 levels.\",\n      \"method\": \"Co-immunoprecipitation, CBP acetyltransferase activity assay, subcellular fractionation, catalytic mutant USP12, p-STAT1 dephosphorylation assay\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — enzymatic assay for CBP inhibition plus localization with functional readout, single study\",\n      \"pmids\": [\"31899788\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"USP12 interacts with, deubiquitylates, and stabilizes HMGB1, sustaining HMGB1-mediated pro-survival autophagy and contributing to bortezomib resistance in multiple myeloma.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, USP12 knockdown, autophagy flux assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP plus deubiquitination assay with functional autophagy phenotype, single lab\",\n      \"pmids\": [\"34997217\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"USP12 deubiquitinates and stabilizes PPM1B (a phosphatase), and USP12 downregulation causes insufficient PPM1B deubiquitination leading to NF-κB hyperactivation in tumor cells, creating an immunosuppressive microenvironment.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, USP12 KO mouse lung tumor model, NF-κB reporter\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO model plus biochemical deubiquitination assay, single lab\",\n      \"pmids\": [\"34381028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"USP12 stabilizes BCL10 by deubiquitinating it, thereby activating NF-κB signaling specifically in CD4+ T cells to promote their activation, differentiation, and proliferation.\",\n      \"method\": \"USP12-KO mouse model, co-immunoprecipitation, ubiquitination assay, NF-κB signaling assay, CD4+ T cell functional assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse plus biochemical deubiquitination assay, single lab\",\n      \"pmids\": [\"33941870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"USP12 binds and stabilizes p300 by deubiquitination, upregulating p300-dependent transcription of METTL3, which catalyzes m6A modification on mRNAs and promotes cardiac hypertrophy.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, USP12 KO/OE in cardiomyocytes and in vivo, METTL3 rescue experiment\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP plus ubiquitination assay with in vivo model, single lab\",\n      \"pmids\": [\"34339675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"USP12 deubiquitinates and stabilizes midkine (MDK) in breast cancer cells, preventing its polyubiquitination-mediated degradation and promoting tumor angiogenesis.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, MDK overexpression rescue, HUVEC tube formation and migration assays, in vivo metastasis model\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct Co-IP plus deubiquitination assay with functional rescue, single lab\",\n      \"pmids\": [\"34759262\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"USP12 deubiquitinates and stabilizes p65 (NF-κB subunit) in monocytic MDSCs, upregulating iNOS and PD-L1 expression to suppress CD8+ T cell responses and promote tumor immune evasion.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, USP12-KO mouse model, T cell suppression assay\",\n      \"journal\": \"Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — KO model plus biochemical deubiquitination, single lab\",\n      \"pmids\": [\"35898171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"USP12 interacts with Bax and removes K63-linked ubiquitin chains from Bax (at K128 and K190 sites), affecting Bax protein half-life without targeting it for proteasomal degradation.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, site-directed mutagenesis of Bax ubiquitination sites, half-life assay\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Y2H plus mutagenesis of ubiquitination sites, but functional consequence of K63-deubiquitination not fully resolved\",\n      \"pmids\": [\"36361894\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"USP12 inhibits proteasome-dependent degradation of IFI16 through its deubiquitinase activity, maintaining IFI16 stability and promoting IFI16-STING-IRF3/p65-mediated antiviral signaling against HSV-1.\",\n      \"method\": \"USP12 KO/KD, co-immunoprecipitation, ubiquitination assay, IFN-β/ISG expression assay, viral replication assay\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — KO plus deubiquitination assay with defined antiviral signaling readout, single lab\",\n      \"pmids\": [\"37410794\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"USP12 directly interacts with and deubiquitinates RRM2 (ribonucleotide reductase catalytic subunit), stabilizing it in non-small cell lung cancer cells; USP12 knockdown causes DNA replication stress.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, USP12 KD, DNA replication stress markers, in vivo tumor growth assay\",\n      \"journal\": \"Molecular carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct Co-IP and deubiquitination assay with functional DNA replication readout, single lab\",\n      \"pmids\": [\"37341611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"USP12/46-WDR48-WDR20 ternary complex removes ubiquitin from the cytoplasmic tail of internalized β1 integrin (Itgb1) in early endosomes, preventing ESCRT-mediated sorting and lysosomal degradation, thereby stabilizing integrin surface levels.\",\n      \"method\": \"Genetic screen, proximity-dependent biotin identification (BioID), co-immunoprecipitation, integrin surface level assay, ESCRT pathway analysis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — BioID plus genetic screen with mechanistic deubiquitination in endosomal trafficking context, preprint\",\n      \"pmids\": [\"bio_10.1101_2024.05.14.594138\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"WDR20 and USP12/46 co-deubiquitinate c-Myc simultaneously to maintain its stability; WDR20 silencing disturbs c-Myc protein stability, promoting CDKN1A transcription and HCC cellular senescence.\",\n      \"method\": \"siRNA screen of WDR-domain proteins, co-immunoprecipitation, ubiquitination assay, ChIP, patient-derived organoids, xenograft and transgenic mouse models\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — biochemical deubiquitination assay with multiple in vivo models, single lab\",\n      \"pmids\": [\"39432777\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"USP12 interacts with YAP, inhibits K48-linked polyubiquitination of YAP at K315, and stabilizes YAP in the nucleus to promote Hippo/YAP signaling in gastric cancer.\",\n      \"method\": \"DUB siRNA library screen, co-immunoprecipitation, ubiquitination site mutagenesis (K315R), immunostaining for nuclear localization, in vitro and in vivo tumor growth assays\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — DUB library screen plus mutagenesis of ubiquitination site and nuclear localization assay, single lab\",\n      \"pmids\": [\"38605077\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DMWD (dystrophia myotonica WD repeat protein), analogous to WDR20, directly binds USP12 at the same interface as WDR20 (suggesting mutually exclusive binding), promotes USP12 enzymatic activity, but differentially modulates USP12 subcellular localization compared to WDR20.\",\n      \"method\": \"Co-immunoprecipitation of epitope-tagged proteins, enzymatic activity assay, subcellular localization imaging, phylogenetic analysis\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct Co-IP plus enzymatic assay and localization experiment, single lab\",\n      \"pmids\": [\"33844468\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"METTL3/YTHDF1-mediated m6A modification stabilizes USP12 mRNA; elevated USP12 then interacts with and deubiquitinates FOXO3, preventing its ubiquitin-mediated degradation and leading to PUMA upregulation and intrinsic apoptosis in sepsis-induced myocardial dysfunction.\",\n      \"method\": \"Proteomic profiling, m6A modification analysis, co-immunoprecipitation, ubiquitination assay, in vitro/in vivo LPS-SIMD model, pathway inhibitor experiments\",\n      \"journal\": \"Molecular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP plus ubiquitination assay with in vivo model, single lab\",\n      \"pmids\": [\"39662205\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"USP12 is a deubiquitinating enzyme that forms an obligate ternary complex with UAF1 (WDR48) and WDR20 (or DMWD) for full enzymatic activation; this complex deubiquitinates a broad range of substrates—including histones H2A/H2B, the androgen receptor, MDM2, Notch, PHLPP1/2, LAT, Trat1, BCL10, p65, HMGB1, IFI16, YAP, RRM2, midkine, β1 integrin, c-Myc, FOXO3, p300, PPM1B, and Bax—to regulate their stability and thereby control diverse processes including transcription, PI3K-Akt-NF-κB signaling, TCR and innate immune signaling, Notch and Hippo pathway trafficking, autophagy, cell cycle progression, and integrin recycling; additionally, USP12 can inhibit CBP acetyltransferase activity independently of its catalytic DUB function, and its subcellular localization (plasma membrane, cytoplasm, nucleus) is dynamically regulated by WDR20 via CRM1-dependent nuclear export.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"USP12 is a deubiquitinating enzyme that functions as the catalytic subunit of a ternary complex with the WD40-repeat proteins UAF1 (WDR48) and WDR20, which are required for full enzymatic activation and proper subcellular localization [PMID:20147737, PMID:27650958, PMID:30466959]. The USP12–UAF1–WDR20 complex deubiquitinates a remarkably broad substrate repertoire—including histones H2A/H2B, the androgen receptor, PHLPP phosphatases, Notch, MDM2, NF-κB pathway components (BCL10, p65, PPM1B), innate immune sensors (IFI16), and endosomal cargo (β1 integrin)—thereby stabilizing these proteins and controlling transcription, PI3K–Akt signaling, TCR and innate immune signaling, Notch trafficking, and integrin recycling [PMID:21183687, PMID:24056413, PMID:24145035, PMID:22778262, PMID:26811477, PMID:33941870, PMID:37410794]. In addition to its catalytic deubiquitinase function, USP12 inhibits CBP acetyltransferase activity through a non-catalytic mechanism, sustaining nuclear phospho-STAT1 during interferon signaling [PMID:31899788]. USP12 dynamically shuttles between the plasma membrane, cytoplasm, and nucleus via CRM1-dependent export directed by WDR20, with TCR or IFN stimulation triggering redistribution that dictates substrate access [PMID:30466959, PMID:26811477].\",\n  \"teleology\": [\n    {\n      \"year\": 2010,\n      \"claim\": \"Identification of USP12 as a histone-directed DUB and discovery of its obligate activator UAF1/WDR48 established that USP12 requires a WD40-repeat cofactor for catalytic competence, setting it apart from most USP-family members.\",\n      \"evidence\": \"In vitro deubiquitination of nucleosomal H2A/H2B, co-IP with WDR48, Xenopus knockdown/overexpression with ChIP\",\n      \"pmids\": [\"21183687\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether UAF1 binding induces conformational change or allosteric activation was unresolved\", \"Relative contributions of H2A vs H2B deubiquitination to transcriptional output not determined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Discovery that WDR20 forms a ternary complex with USP12–UAF1 and specifically stimulates USP12 (but not USP1) activity revealed a second cofactor layer that distinguishes USP12/USP46 from other UAF1-dependent DUBs.\",\n      \"evidence\": \"Tandem affinity purification, in vitro DUB activity assay with recombinant ternary complex\",\n      \"pmids\": [\"20147737\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which WDR20 stimulates activity unknown at this point\", \"Physiological substrates of the full ternary complex not yet identified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrating that USP12 deubiquitinates non-activated Notch to promote its lysosomal trafficking revealed the first non-histone substrate and placed USP12 in endosomal sorting, where deubiquitination paradoxically promotes degradation rather than stabilization.\",\n      \"evidence\": \"shRNA screen, in vitro DUB assay on Notch, trafficking assay by flow cytometry and confocal imaging, Drosophila homolog validation\",\n      \"pmids\": [\"22778262\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether USP12 acts on Notch at the plasma membrane vs endosome not resolved\", \"Identity of the E3 ligase counteracting USP12 on Notch unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identification of the androgen receptor and PHLPP phosphatases as USP12 substrates connected the enzyme to two converging oncogenic pathways—AR transcription and PI3K–Akt signaling—in prostate cancer.\",\n      \"evidence\": \"Co-IP, ubiquitination/deubiquitination assays, Akt phosphorylation and AR reporter assays in prostate cancer cells\",\n      \"pmids\": [\"24056413\", \"24145035\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether AR and PHLPP are deubiquitinated by the same pool of USP12 complex unknown\", \"No structural basis for substrate recognition\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"The crystal structure of USP12–Ub bound to UAF1 resolved the activation mechanism, revealing a 1:2 stoichiometry with high- and low-affinity UAF1 binding sites mediated by the USP12 fingers subdomain.\",\n      \"evidence\": \"X-ray crystallography at 2.8 Å, mutagenesis, binding stoichiometry assays\",\n      \"pmids\": [\"27650958\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the full ternary complex including WDR20 not determined\", \"Structural basis for substrate selectivity remains unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showing that USP12 is phosphorylated and translocates from nucleus to cytosol upon TCR stimulation to deubiquitinate LAT and Trat1 established USP12 as a signal-dependent effector in adaptive immunity that maintains proximal TCR signaling complexes.\",\n      \"evidence\": \"Activity-based DUB probes, USP12-KO Jurkat cells with rescue, BioID proximity labeling, co-IP, flow cytometry\",\n      \"pmids\": [\"26811477\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase responsible for USP12 phosphorylation not identified\", \"Whether USP12 acts similarly in primary human T cells not confirmed\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Characterization of USP12's dynamic subcellular shuttling—WDR20 recruits USP12 to the plasma membrane while CRM1-dependent export controls nuclear exit—explained how a single DUB accesses substrates in distinct compartments.\",\n      \"evidence\": \"Confocal and live-cell microscopy, mutagenesis of N-terminal MEIL motif, leptomycin B treatment\",\n      \"pmids\": [\"30466959\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of membrane localization for specific substrates not defined\", \"Whether phosphorylation regulates this shuttling is untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Discovery that USP12 inhibits CBP acetyltransferase activity independently of its DUB catalytic function revealed a non-enzymatic role in sustaining nuclear phospho-STAT1 during IFN signaling, broadening USP12's functional repertoire beyond deubiquitination.\",\n      \"evidence\": \"CBP HAT activity assay with catalytic-dead USP12 mutant, subcellular fractionation, p-STAT1 dephosphorylation assay\",\n      \"pmids\": [\"31899788\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis for CBP HAT domain inhibition not resolved\", \"Whether this non-catalytic function extends to other acetyltransferases untested\", \"Single-study finding\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"A burst of substrate identifications—HMGB1, PPM1B, BCL10, p300, midkine, Bax, and DMWD as an alternative WDR20-like cofactor—collectively demonstrated that USP12 is a broadly acting stabilizer of signaling regulators across NF-κB, autophagy, apoptosis, and epigenetic pathways.\",\n      \"evidence\": \"Multiple independent Co-IP and ubiquitination assays, KO mouse models (PPM1B, BCL10), autophagy flux (HMGB1), cardiomyocyte models (p300), Bax mutagenesis\",\n      \"pmids\": [\"34997217\", \"34381028\", \"33941870\", \"34339675\", \"34759262\", \"36361894\", \"33844468\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Most substrates validated by single labs; independent replication needed\", \"Hierarchy or competition among substrates for USP12 binding is unexplored\", \"Whether DMWD and WDR20 direct USP12 to distinct substrate pools is unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identification of IFI16 and RRM2 as USP12 substrates extended its roles to innate antiviral immunity (IFI16–STING–IRF3 axis) and DNA replication (dNTP supply via RRM2 stability), linking USP12 to genome maintenance.\",\n      \"evidence\": \"USP12 KO/KD with Co-IP and ubiquitination assays, IFN-β/ISG induction and viral replication assays (IFI16), DNA replication stress markers and in vivo tumor growth (RRM2)\",\n      \"pmids\": [\"37410794\", \"37341611\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether USP12 regulates RRM2 during normal S-phase or only under oncogenic stress unclear\", \"Redundancy with USP46 for these substrates not assessed\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Studies on YAP, c-Myc, β1 integrin, and FOXO3 further expanded the USP12 substrate repertoire to Hippo signaling, oncogene stabilization, endosomal integrin recycling, and sepsis-induced apoptosis, underscoring USP12 as a context-dependent stabilizer of diverse signaling nodes.\",\n      \"evidence\": \"DUB siRNA screens, BioID and genetic screens (integrin), Co-IP with ubiquitination site mutagenesis (YAP K315), patient-derived organoids and transgenic mice (c-Myc), LPS-SIMD models (FOXO3)\",\n      \"pmids\": [\"38605077\", \"39432777\", \"39662205\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Integrin deubiquitination data from preprint awaiting peer review\", \"How USP12 distinguishes >20 substrates through a single catalytic domain lacks structural explanation\", \"Relative physiological importance of individual substrates in vivo not ranked\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: (1) the structural basis for WDR20/DMWD-dependent activation and substrate selectivity in the full ternary complex, (2) whether distinct cofactor combinations (WDR20 vs DMWD) channel USP12 to specific substrate pools in vivo, and (3) how signal-dependent post-translational modifications orchestrate USP12 localization and substrate access across its many reported pathways.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structure of USP12–UAF1–WDR20 ternary complex\", \"Kinase(s) and phosphorylation sites controlling USP12 relocalization unidentified\", \"Systematic comparison of USP12 vs USP46 substrate specificity lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 2, 3, 4, 6, 8, 11, 12, 13, 14, 15, 16, 17, 18, 19, 22, 24]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [6, 9, 10, 22]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6, 9]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [9]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [4, 20]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 4, 6, 7, 12, 13, 16, 22]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [6, 13, 16, 18]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 8, 14]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [17, 24]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [11]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [4, 20]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [8, 15, 19, 21, 22]}\n    ],\n    \"complexes\": [\n      \"USP12–UAF1(WDR48)–WDR20 ternary complex\",\n      \"USP12–UAF1(WDR48)–DMWD ternary complex\"\n    ],\n    \"partners\": [\n      \"WDR48\",\n      \"WDR20\",\n      \"DMWD\",\n      \"AR\",\n      \"PHLPP1\",\n      \"CREBBP\",\n      \"MDM2\",\n      \"LAT\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}